Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.85
-7.50 (-0.80%) Cadila Healthcare reports 52% rise in Q3 consolidated net profit
Date: 10-02-2015Cadila Healthcare has reported results for third quarter ended December 31, 2014.
The company has registered a rise of 85.28% in its net profit at Rs 361.16 crore for the quarter under review as compared to Rs 194.93 crore for the same quarter in the previous year. Total income of the company increased by 35.64% at Rs 1475.06 crore for Q3FY15 as compared Rs 1087.48 crore for the corresponding quarter previous year.
On the consolidated basis the company’s net profit rose 51.59% to Rs 281.91 crore for the Q3 FY15, as compared to Rs 185.97 crore in Q3 FY14. Moreover, the total income increased 16.72% to Rs 2199.47 crore in the quarter under review as compared to Rs 1884.47 crore in the corresponding quarter previous year.